Fuller & Thaler Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,800	Closed	-$598K	–	491
2018 Q2	$598K	Hold	10,800	–	–	0.01%	345
2018 Q1	$683K	Sell	10,800 -6,400	-37%	-$412K	0.01%	334
2017 Q4	$1.05M	Hold	17,200	–	–	0.01%	310
2017 Q3	$1.1M	Buy	17,200 +4,100	+31%	+$239K	0.01%	285
2017 Q2	$730K	Buy	+13,100	New	+$713K	0.01%	298
2015 Q3	–	Sell	-9,400	Closed	-$625K	–	673
2015 Q2	$625K	Sell	9,400 -5,150	-35%	-$339K	0.02%	292
2015 Q1	$938K	Buy	14,550 +11,600	+393%	+$726K	0.03%	272
2014 Q4	$174K	Sell	2,950 -9,000	-75%	-$508K	0.01%	411
2014 Q3	$612K	Hold	11,950	–	–	0.03%	309
2014 Q2	$580K	Sell	11,950 -2,100	-15%	-$103K	0.02%	307
2014 Q1	$730K	Sell	14,050 -5,900	-30%	-$314K	0.04%	281
2013 Q4	$1.06M	Buy	19,950 +1,300	+7%	+$66.2K	0.06%	252
2013 Q3	$863K	Buy	18,650 +9,700	+108%	+$426K	0.05%	262
2013 Q2	$400K	Buy	+8,950	New	+$389K	0.03%	302

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fuller & Thaler Asset Management's BMY Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 10,800 shares — an estimated $598K sold.

Fuller & Thaler Asset Management first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $1.1M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Fuller & Thaler Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Fuller & Thaler Asset Management sold 10,800 Bristol-Myers Squibb shares in Q3 2018, an estimated $598K.
Fuller & Thaler Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
Fuller & Thaler Asset Management's Bristol-Myers Squibb position peaked at $1.1M in Q3 2017.
1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.